Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms.

Abstract:

BACKGROUND:Proprotein convertase subtilisin kexin 9 (PCSK9) targets the LDL-receptor (LDLR) which raises LDL-levels. In addition, PCSK9 has proinflammatory immunological effects. Here, we investigate the role of PCSK9 in relation to the inflammatory activity in patients with rheumatoid arthritis (RA). METHODS:PCSK9-levels were determined at baseline by ELISA in 160 patients with RA not previously treated with biologics. The patients started anti-TNF-α (adalimumab, infliximab, or etanercept) treatment and were followed-up for 1 year. Disease activity was determined by DAS28. Effects of PCSK9 on cytokine production from macrophages of healthy individuals and synoviocytes from RA patients and inhibition by anti-PCSK9 antibodies were studied in supernatants by ELISA. RESULTS:A significantly lower level of PCSK9 at baseline, p = 0.035, was observed in patients who reached remission within 1 year, defined as DAS28 < 2.6, compared to those not in remission. At 12 months of TNF-α antagonist treatment, the mean DAS28 was reduced but was significantly greater in patients with highest quartile PCSK9 (Q4) compared to those at lowest PCSK9 (Q1) in both crude (p = 0.01) and adjusted analysis (p = 0.004). In vitro, PCSK9 induced TNF-alpha and IL-1beta in macrophages and monocyte chemoattractant protein-1 (MCP1) in synoviocytes. These effects were inhibited by anti-PCSK9 antibodies. CONCLUSIONS:Low levels of PCSK9 at baseline are associated with being DAS28-responder to anti-TNF-α treatment in RA. An underlying cause could be that PCSK9 stimulates the production of proinflammatory cytokines from macrophages and synoviocytes, effects inhibited by anti-PCSK9 antibodies. PCSK9 could thus play an immunological role in RA.

journal_name

Arthritis Res Ther

authors

Frostegård J,Ahmed S,Hafström I,Ajeganova S,Rahman M

doi

10.1186/s13075-020-02386-7

subject

Has Abstract

pub_date

2021-01-19 00:00:00

pages

32

issue

1

eissn

1478-6354

issn

1478-6362

pii

10.1186/s13075-020-02386-7

journal_volume

23

pub_type

杂志文章
  • Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis.

    abstract:INTRODUCTION:Broad-range rDNA PCR provides an alternative, cultivation-independent approach for identifying bacterial DNA in reactive and other form of arthritis. The aim of this study was to use broad-range rDNA PCR targeting the 16S rRNA gene in patients with reactive and other forms of arthritis and to screen for th...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2748

    authors: Siala M,Gdoura R,Fourati H,Rihl M,Jaulhac B,Younes M,Sibilia J,Baklouti S,Bargaoui N,Sellami S,Sghir A,Hammami A

    更新日期:2009-01-01 00:00:00

  • Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.

    abstract::Cardiovascular event rates are markedly increased in rheumatoid arthritis (RA), and RA atherogenesis remains poorly understood. The relative contributions of traditional and nontraditional risk factors to cardiovascular disease in RA await elucidation. The present study comprises three components. First, we compared b...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar1717

    authors: Dessein PH,Joffe BI,Singh S

    更新日期:2005-01-01 00:00:00

  • Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.

    abstract:INTRODUCTION:Recent advances suggest that the cellular redox state may play a significant role in the progression of fibrosis in systemic sclerosis (SSc). Another, and as yet poorly accounted for, feature of SSc is its overlap with thyroid abnormalities. Previous reports demonstrate that hypothyroidism reduces oxidant ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4300

    authors: Bagnato G,Bitto A,Irrera N,Pizzino G,Sangari D,Cinquegrani M,Roberts W,Atteritano M,Altavilla D,Squadrito F,Bagnato G,Saitta A

    更新日期:2013-09-16 00:00:00

  • Disturbance of cytokine networks in Sjögren's syndrome.

    abstract::The difficulty in predicting the consequences of interactions between different cytokine networks has increased with the expansion of the T helper (Th) cell universe and the discovery of numerous B lymphocyte-derived cytokines. Consequently, it is now difficult to conceptualize a straightforward view of the contributi...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar3348

    authors: Youinou P,Pers JO

    更新日期:2011-07-06 00:00:00

  • Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.

    abstract::Macrophage activation syndrome (MAS) has been reported in association with many rheumatic diseases, most commonly in systemic juvenile rheumatoid arthritis (sJRA). Clinically, MAS is similar to hemophagocytic lymphohistiocytosis (HLH), a genetic disorder with absent or depressed natural killer (NK) function. We have p...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar1453

    authors: Villanueva J,Lee S,Giannini EH,Graham TB,Passo MH,Filipovich A,Grom AA

    更新日期:2005-01-01 00:00:00

  • Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation.

    abstract:INTRODUCTION:The endoplasmic reticulum (ER) stress-response, evoked in mice by the overexpression of class I major histocompatibility complex antigen (MHC-I), was proposed as a major mechanism responsible for skeletal muscle damage and dysfunction in autoimmune myositis. The present study was undertaken to characterize...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2963

    authors: Vitadello M,Doria A,Tarricone E,Ghirardello A,Gorza L

    更新日期:2010-01-01 00:00:00

  • Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicine.

    abstract::The relationship between serum urate, menopause, and aging has not been clearly defined by scientific evidence. In the present issue of Arthritis Research and Therapy, Hak and Choi present a cross-sectional analysis to clarify the effect of menopause and hormone replacement therapy on serum urate in women within the T...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar2524

    authors: Gaffo AL,Saag KG

    更新日期:2008-01-01 00:00:00

  • Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study.

    abstract:INTRODUCTION:Methotrexate (MTX) is a cornerstone of treatment in a wide variety of inflammatory conditions, including juvenile idiopathic arthritis (JIA) and juvenile dermatomyositis (JDM). However, owing to its narrow therapeutic index and the considerable interpatient variability in clinical response, monitoring of a...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-015-0814-z

    authors: Hawwa AF,AlBawab A,Rooney M,Wedderburn LR,Beresford MW,McElnay JC

    更新日期:2015-10-22 00:00:00

  • Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.

    abstract:INTRODUCTION:Intraarticular administration of autologous conditioned serum (ACS) recently demonstrated some clinical effectiveness in treatment of osteoarthritis (OA). The current study aims to evaluate the in vitro effects of ACS on cartilage proteoglycan (PG) metabolism, its composition and the effects on synovial fl...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3050

    authors: Rutgers M,Saris DB,Dhert WJ,Creemers LB

    更新日期:2010-01-01 00:00:00

  • The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.

    abstract:BACKGROUND:Rheumatoid arthritis (RA) is often characterized by the presence of rheumatoid factor, anti-citrullinated protein antibodies, and bone erosions. Current therapies can compromise immunity, leading to risk of infection. The interleukin-20 receptor (IL-20R) axis comprising IL-19, IL-20, and IL-24 and their shar...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s13075-016-0964-7

    authors: Kragstrup TW,Greisen SR,Nielsen MA,Rhodes C,Stengaard-Pedersen K,Hetland ML,Hørslev-Petersen K,Junker P,Østergaard M,Hvid M,Vorup-Jensen T,Robinson WH,Sokolove J,Deleuran B

    更新日期:2016-03-11 00:00:00

  • MMP-2 mediates local degradation and remodeling of collagen by annulus fibrosus cells of the intervertebral disc.

    abstract:INTRODUCTION:Degeneration of the intervertebral disc (IVD) is characterized by marked degradation and restructuring of the annulus fibrosus (AF). Although several matrix metalloproteinases (MMPs) have been found to be more prevalent in degenerate discs, their coordination and function within the context of the disease ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4224

    authors: Rastogi A,Kim H,Twomey JD,Hsieh AH

    更新日期:2013-04-27 00:00:00

  • Soluble IL-18 receptor complex: a new star in the firmament of rheumatoid arthritis diagnosis?

    abstract::It has long been recognized that laboratory tests are useful in the diagnosis of disease and to monitor treatment outcome. Their performance has become even more demanding with the development of personalized medicine. In patients with rheumatoid arthritis (RA) the standard biochemical tests measure serological marker...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar3308

    authors: van de Loo FA

    更新日期:2011-04-27 00:00:00

  • Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis.

    abstract:INTRODUCTION:Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease primarily involving the synovium. Evidence in recent years has suggested that the bone marrow (BM) may be involved, and may even be the initiating site of the disease. Abnormalities in haemopoietic stem cells' (HSC) survival, proliferation ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3098

    authors: Mohanty ST,Kottam L,Gambardella A,Nicklin MJ,Coulton L,Hughes D,Wilson AG,Croucher PI,Bellantuono I

    更新日期:2010-01-01 00:00:00

  • Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus.

    abstract:BACKGROUND:African Americans with systemic lupus erythematosus (SLE) have increased renal disease compared to Caucasians, but differences in other comorbidities have not been well-described. We used an electronic health record (EHR) technique to test for differences in comorbidities in African Americans compared to Cau...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-018-1561-8

    authors: Barnado A,Carroll RJ,Casey C,Wheless L,Denny JC,Crofford LJ

    更新日期:2018-04-10 00:00:00

  • Suppression of bone morphogenetic protein inhibitors promotes osteogenic differentiation: therapeutic implications.

    abstract::Bone morphogenetic proteins (BMPs) are expressed during osteogenesis and their action is regulated by corresponding BMP inhibitors. Chordin (a well recognized BMP inhibitor) and BMP-2 are expressed during osteogenic differentiation of human mesenchymal stem cells. Chordin inhibition induces human mesenchymal stem cell...

    journal_title:Arthritis research & therapy

    pub_type: 社论

    doi:10.1186/ar2467

    authors: Heliotis M,Tsiridis E

    更新日期:2008-01-01 00:00:00

  • The role of aldosterone blockade in murine lupus nephritis.

    abstract:BACKGROUND:The purpose of this study was to examine the effect of aldosterone receptor blockade on the immunopathogenesis and progression of nephritis in the (NZB x NZW) F1 murine lupus model. METHODS:Female NZB/W F1 mice (11 weeks old) were treated daily with 25 or 50 mg/kg oral spironolactone or vehicle. Proteinuria...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2353

    authors: Monrad SU,Killen PD,Anderson MR,Bradke A,Kaplan MJ

    更新日期:2008-01-01 00:00:00

  • Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.

    abstract:BACKGROUND:Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc), associated with a progressive elevation in pulmonary vascular resistance and subsequent right heart failure and death. Due to unspecific symptoms, the diagnosis of PAH is often delayed. On this basis, it is of great v...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-02218-8

    authors: Di Benedetto P,Guggino G,Manzi G,Ruscitti P,Berardicurti O,Panzera N,Grazia N,Badagliacca R,Riccieri V,Vizza CD,Radchenko G,Liakouli V,Ciccia F,Cipriani P,Giacomelli R

    更新日期:2020-06-01 00:00:00

  • DMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviews.

    abstract:INTRODUCTION:Disease-modifying antirheumatic drugs (DMARDs) have become the treatment standard for patients with rheumatoid arthritis (RA). Although several general-population studies document that a large population of patients diagnosed with RA do not use DMARDs, little is known about this group. We explored the char...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4459

    authors: Brown EM,Garneau KL,Tsao H,Solomon DH

    更新日期:2014-01-29 00:00:00

  • Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group.

    abstract:BACKGROUND:The long-term outcome of rheumatoid arthritis (RA) patients who in clinical practice exhibit persistent moderate disease activity (pMDA) despite treatment with biologics has not been adequately studied. Herein, we analyzed the 5-year outcome of the pMDA group and assessed for within-group heterogeneity. MET...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-02313-w

    authors: Genitsaridi I,Flouri I,Plexousakis D,Marias K,Boki K,Skopouli F,Drosos A,Bertsias G,Boumpas D,Sidiropoulos P

    更新日期:2020-09-29 00:00:00

  • Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis.

    abstract:INTRODUCTION:Studies in the spontaneous ankylosis model in aging male DBA/1 mice and in patients with ankylosing spondylitis provide evidence that inflammation and new tissue formation leading to joint or spine ankylosis are likely linked but largely uncoupled processes. We previously proposed the 'entheseal stress' hy...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3772

    authors: Braem K,Deroose CM,Luyten FP,Lories RJ

    更新日期:2012-03-12 00:00:00

  • Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study.

    abstract:BACKGROUND:With advancement in the treatment options of rheumatoid arthritis (RA), optimising the outcomes of difficult-to-treat patients has become increasingly important in clinical practice. In particular, insensitivity to first-line biologic disease-modifying anti-rheumatic drugs (bDMARD) is becoming a significant ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-2122-5

    authors: Ochi S,Saito K,Mizoguchi F,Kato S,Tanaka Y

    更新日期:2020-03-04 00:00:00

  • Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial.

    abstract:INTRODUCTION:Pateclizumab (MLTA3698A) is a humanized mAb against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis. This study was conducted to assess the safety, tolerability, < NOTE: For clarity and per AMA/S-W ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/ar3554

    authors: Emu B,Luca D,Offutt C,Grogan JL,Rojkovich B,Williams MB,Tang MT,Xiao J,Lee JH,Davis JC

    更新日期:2012-01-08 00:00:00

  • Gene expression identifies patients who develop inflammatory arthritis in a clinically suspect arthralgia cohort.

    abstract:BACKGROUND:Established rheumatoid arthritis (RA) patients display differentially expressed genes coding for cytokine/chemokine-mediated immunity compared to healthy controls. It is unclear, however, if in the pre-arthritis phase of clinically suspect arthralgia (CSA) expression of immune genes differ between patients w...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-02361-2

    authors: Niemantsverdriet E,van den Akker EB,Boeters DM,van den Eeden SJF,Geluk A,van der Helm-van Mil AHM

    更新日期:2020-11-09 00:00:00

  • Stratifying primary Sjögren's syndrome: killers in the balance?

    abstract::The article by Seror et al. in Arthritis Research & Therapy reports data from the 15 French patients in the open-label BELISS (Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome, NCT01160666) study of belimumab in primary Sjögren's syndrome. The study identifies that higher baseline levels of...

    journal_title:Arthritis research & therapy

    pub_type: 社论

    doi:10.1186/s13075-015-0878-9

    authors: Bowman SJ,Fisher BA

    更新日期:2015-12-07 00:00:00

  • The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.

    abstract:INTRODUCTION:The aim was to evaluate S100A4 protein as a biomarker of disease activity and potential cancer development in patients with myositis. METHODS:Serum levels of S100A4 were determined in 43 dermatomyositis (DM), 39 polymyositis (PM) and 22 cancer associated myositis (CAM) patients as well as in 77 healthy co...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-014-0468-2

    authors: Pleštilová L,Mann H,Andrés Cerezo L,Pecha O,Vencovský J,Šenolt L

    更新日期:2014-10-31 00:00:00

  • Giant cell arteritis: immune and vascular aging as disease risk factors.

    abstract::Susceptibility for giant cell arteritis increases with chronological age, in parallel with age-related restructuring of the immune system and age-induced remodeling of the vascular wall. Immunosenescence results in shrinkage of the naïve T-cell pool, contraction of T-cell diversity, and impairment of innate immunity. ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar3358

    authors: Mohan SV,Liao YJ,Kim JW,Goronzy JJ,Weyand CM

    更新日期:2011-08-02 00:00:00

  • Differential expression of CD148 on leukocyte subsets in inflammatory arthritis.

    abstract:INTRODUCTION:Monocytic cells play a central role in the aetiology of rheumatoid arthritis, and manipulation of the activation of these cells is an approach currently under investigation to discover new therapies for this and associated diseases. CD148 is a transmembrane tyrosine phosphatase that is highly expressed in ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4288

    authors: Dave RK,Naylor AJ,Young SP,Bayley R,Hardie DL,Haworth O,Rider DA,Cook AD,Buckley CD,Kellie S

    更新日期:2013-01-01 00:00:00

  • Developments in the scientific and clinical understanding of autoinflammatory disorders.

    abstract::The autoinflammatory diseases, also known as periodic fever syndromes, are disorders of innate immunity which can be inherited or acquired and which cause recurrent, self-limiting, seemingly spontaneous episodes of systemic inflammation and fever in the absence of autoantibody production or infection. There has been m...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2579

    authors: Lachmann HJ,Hawkins PN

    更新日期:2009-01-01 00:00:00

  • Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.

    abstract:BACKGROUND:As an initial step in the development of a local therapeutic to treat osteoarthritis (OA), a number of agents were tested for their ability to block activation of inflammation through nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB), subchondral bone changes through receptor activator of nu...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-016-0921-5

    authors: TenBroek EM,Yunker L,Nies MF,Bendele AM

    更新日期:2016-01-21 00:00:00

  • The role of HIF-1alpha in maintaining cartilage homeostasis and during the pathogenesis of osteoarthritis.

    abstract::As a consequence of the avascular nature of cartilage the microenvironment in which chondrocytes must exist is characterized by hostile conditions, most prominently very low levels of oxygen (hypoxia). In recent years, a vast number of papers reporting on the role of hypoxia in cartilage development and disease has be...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar1894

    authors: Pfander D,Swoboda B,Cramer T

    更新日期:2006-01-01 00:00:00